4.5 Article

Ginsenoside Rg1 treatment alleviates renal fibrosis by inhibiting the NOX4-MAPK pathway in T2DM mice

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Endocrinology & Metabolism

Body Mass Index and Risk of Diabetic Nephropathy: A Mendelian Randomization Study

Jingru Lu et al.

Summary: The study found that an increase in body mass index was causally associated with a higher risk of diabetic nephropathy and a lower eGFR level in type 2 diabetes patients. The impact of BMI on DN risk was greater in women, but there was no causal association with proteinuria.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Article Medicine, Research & Experimental

Ginsenoside Rg1 attenuates LPS-induced chronic renal injury by inhibiting NOX4-NLRP3 signaling in mice

Duoduo Zhang et al.

Summary: Ginsenoside Rg1 has a protective effect against chronic renal injury induced by low-dose lipopolysaccharide (LPS), possibly by reducing oxidative stress and inhibiting inflammasome activation.

BIOMEDICINE & PHARMACOTHERAPY (2022)

Review Oncology

TGF-β in developmental and fibrogenic EMTs

Jun Ho Lee et al.

Summary: TGF-beta plays a crucial role in development, wound healing, fibrosis, and cancer by inducing epithelial-mesenchymal transitions (EMTs). EMTs are regulated by multiple signaling inputs, with RAS-MAPK signaling frequently required for EMT induction by TGF-beta. Recent studies have revealed the molecular basis for the cooperation between the TGF-beta-SMAD and RAS-MAPK pathways in EMT induction, offering insights into EMT and progenitor cell differentiation during gastrulation and cancer metastasis.

SEMINARS IN CANCER BIOLOGY (2022)

Article Endocrinology & Metabolism

Association between the metabolic profile of serum fatty acids and diabetic nephropathy: a study conducted in northeastern China

Yazhuo Liu et al.

Summary: This study found that the levels of nervonic acid (NA) and docosahexaenoic acid (DHA) in patients with diabetic nephropathy (DN) were relatively low, and that DHA was negatively correlated with microalbuminuria (MAU) and the albumin/creatinine ratio (ACR). However, larger population-based studies are still needed to investigate the role of NA and DHA in the pathogenesis of DN.

THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM (2022)

Article Endocrinology & Metabolism

Guidelines for measuring reactive oxygen species and oxidative damage in cells and in vivo

Michael P. Murphy et al.

Summary: This article discusses the important roles of reactive oxygen species (ROS) in health and disease, and proposes guidelines and best practices for the nomenclature and assessment of ROS, oxidative reactions, and oxidative damage in cells, tissues, and in vivo.

NATURE METABOLISM (2022)

Review Biochemistry & Molecular Biology

Signaling pathways of chronic kidney diseases, implications for therapeutics

Qian Yuan et al.

Summary: This article reviews the key signaling pathways involved in lipotoxicity, oxidative stress, inflammation, and myofibroblast activation in chronic kidney disease (CKD), and introduces targeted drugs based on the latest research. Understanding these signaling pathways and developing targeted therapies will advance basic and clinical research in CKD.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

Article Endocrinology & Metabolism

Association between the triglyceride-glucose index and diabetic nephropathy in patients with type 2 diabetes: A cross-sectional study

Li Liu et al.

Summary: The study investigated the association between the TyG index and diabetic nephropathy in patients with type 2 diabetes, showing that the TyG index was independently associated with DN and a better marker than HOMA2-IR for DN identification in type 2 diabetes patients. The TyG index was positively correlated with metabolic indicators and was identified as an independent risk factor for DN.

JOURNAL OF DIABETES INVESTIGATION (2021)

Article Cell Biology

Salvianolate ameliorates oxidative stress and podocyte injury through modulation of NOX4 activity in db/db mice

Yiran Liang et al.

Summary: In this study, the effects of Salvianolate on diabetic nephropathy were investigated, showing that Salvianolate attenuated albuminuria, reduced podocyte loss, and restored podocyte loss in diabetic kidneys. Moreover, Salvianolate blocked HG-induced mitochondrial NOX4 derived superoxide generation in human podocytes, ameliorating podocyte apoptosis.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)

Article Oncology

Ginsenoside Rg1 attenuates the inflammation and oxidative stress induced by diabetic nephropathy through regulating the PI3K/ AKT/FOXO3 pathway

Hui Liu et al.

Summary: The study showed that Rg1 treatment effectively improved cell viability, reduced apoptosis, attenuated inflammatory response, and alleviated oxidative stress induced by high glucose. In addition, Rg1 treatment in DN rats model demonstrated anti-inflammatory and antioxidant activities, and regulated the PI3K/AKT/FOXO3 pathway both in vitro and in vivo, suggesting its potential as a therapeutic agent for DN treatment.

ANNALS OF TRANSLATIONAL MEDICINE (2021)

Article Endocrinology & Metabolism

Kidney disease in diabetes: From mechanisms to clinical presentation and treatment strategies

Carlo Alberto Ricciardi et al.

Summary: Metabolic and haemodynamic perturbations play a key role in the development and progression of diabetic kidney disease (DKD). Controlling metabolic, lipid, and blood pressure levels is crucial in slowing the progression of DKD. Therapies targeting haemodynamic perturbations, such as inhibitors of the renin-angiotensin-aldosterone system (RAAS) and SGLT2 inhibitors, have shown success in the prevention and management of DKD.

METABOLISM-CLINICAL AND EXPERIMENTAL (2021)

Article Oncology

Ginsenoside Rg1 ameliorates aging-induced liver fibrosis by inhibiting the NOX4/NLRP3 inflammasome in SAMP8 mice

Yan Li et al.

Summary: The study demonstrated that Ginsenoside Rg1 (Rg1) can significantly improve aging-induced liver injury and fibrosis, reduce the expression levels of collagen IV and TGF-beta 1, and potentially alleviate liver damage by reducing NOX4-mediated ROS oxidative stress and inhibiting NLRP3 inflammasome activation.

MOLECULAR MEDICINE REPORTS (2021)

Article Plant Sciences

Schisantherin A ameliorates liver fibrosis through TGF-β1mediated activation of TAK1/MAPK and NF-κB pathways in vitro and in vivo

Haili Wang et al.

Summary: The study found that SCA can significantly inhibit liver fibrosis induced by TAA through suppressing the TGF-beta 1-mediated TAK1/MAPK and NF-kappa B signaling pathways to inhibit the activation of HSCs and inflammatory response.

PHYTOMEDICINE (2021)

Article Biochemistry & Molecular Biology

Inhibition of ferroptosis by up-regulating Nrf2 delayed the progression of diabetic nephropathy

Shuangwen Li et al.

Summary: Our research demonstrated the involvement of ferroptosis in the development of DN, and up-regulating Nrf2 with fenofibrate treatment inhibited diabetes-related ferroptosis, delaying the progression of DN. This study provided a new perspective on the development mechanism of DN and offered a new approach to delay the progression of DN.

FREE RADICAL BIOLOGY AND MEDICINE (2021)

Review Pharmacology & Pharmacy

The Growing Epidemic of Diabetes Mellitus

Dragan Lovic et al.

CURRENT VASCULAR PHARMACOLOGY (2020)

Article Medicine, Research & Experimental

Atorvastatin attenuates TGF-β1-induced fibrogenesis by inhibiting Smad3 and MAPK signaling in human ventricular fibroblasts

Yanfei Du et al.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2020)

Review Biochemistry & Molecular Biology

Organophosphorus Compounds and MAPK Signaling Pathways

Tahereh Farkhondeh et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Endocrinology & Metabolism

Unique Metabolic Features of Adults Discordant for Indices of Insulin Resistance

Yilin Song et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)

Article Pharmacology & Pharmacy

Huidouba Improved Podocyte Injury by Down-Regulating Nox4 Expression in Rats With Diabetic Nephropathy

KunBao Yang et al.

FRONTIERS IN PHARMACOLOGY (2020)

Review Endocrinology & Metabolism

Type 2 diabetes mellitus: pathogenesis and genetic diagnosis

D. Himanshu et al.

JOURNAL OF DIABETES AND METABOLIC DISORDERS (2020)

Article Biochemistry & Molecular Biology

Salidroside Ameliorates Renal Interstitial Fibrosis by Inhibiting the TLR4/NF-B and MAPK Signaling Pathways

Rui Li et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Review Pharmacology & Pharmacy

Diabetic nephropathy: an insight into molecular mechanisms and emerging therapies

Annabelle M. Warren et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2019)

Article Medicine, Research & Experimental

lncRNA NR_038323 Suppresses Renal Fibrosis in Diabetic Nephropathy by Targeting the miR-324-3p/DUSP1 Axis

Yanni Ge et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2019)

Article Biochemistry & Molecular Biology

Hesperetin relieves cisplatin-induced acute kidney injury by mitigating oxidative stress, inflammation and apoptosis

Xinliang Chen et al.

CHEMICO-BIOLOGICAL INTERACTIONS (2019)

Review Nutrition & Dietetics

Changes in Plasma Free Fatty Acids Associated with Type-2 Diabetes

Amelie I. S. Sobczak et al.

NUTRIENTS (2019)

Article Pharmacology & Pharmacy

Investigations on the effects of ginsenoside-Rg1 on glucose uptake and metabolism in insulin resistant HepG2 cells

Xiaoming Fan et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2019)

Article Endocrinology & Metabolism

Plasma levels of free fatty acids correlate with type 2 diabetes mellitus

Sandro Spiller et al.

DIABETES OBESITY & METABOLISM (2018)

Review Biochemistry & Molecular Biology

Nox4 in renal diseases: An update

Qin Yang et al.

FREE RADICAL BIOLOGY AND MEDICINE (2018)

Review Urology & Nephrology

CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease

Hans-Joachim Anders et al.

NATURE REVIEWS NEPHROLOGY (2018)

Article Biochemistry & Molecular Biology

miR-423-5p suppresses high-glucose-induced podocyte injury by targeting Nox4

Yuxiang Xu et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)

Article Pharmacology & Pharmacy

Naringin ameliorates diabetic nephropathy by inhibiting NADPH oxidase 4

Junwei Zhang et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2017)

Article Biochemistry & Molecular Biology

Lipoxin A4 attenuates LPS-induced mouse acute lung injury via Nrf2-mediated E-cadherin expression in airway epithelial cells

Xue Cheng et al.

FREE RADICAL BIOLOGY AND MEDICINE (2016)

Article Biochemical Research Methods

Quantifying ROS levels using CM-H2DCFDA and HyPer

Monika Oparka et al.

METHODS (2016)

Review Cell Biology

ROS and ROS-Mediated Cellular Signaling

Jixiang Zhang et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)

Article Biochemistry & Molecular Biology

Renal Protective Effects of Low Molecular Weight of Inonotus obliquus Polysaccharide (LIOP) on HFD/STZ-Induced Nephropathy in Mice

Yen-Jung Chou et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)

Review Medicine, Research & Experimental

Nox and renal disease

Chet E. Holterman et al.

CLINICAL SCIENCE (2015)

Article Medicine, General & Internal

Diabetic kidney disease

Merlin C. Thomas et al.

NATURE REVIEWS DISEASE PRIMERS (2015)

Review Medicine, General & Internal

Intracellular lipid accumulation and shift during diabetes progression

Peter Wolf et al.

WIENER MEDIZINISCHE WOCHENSCHRIFT (2014)

Review Cardiac & Cardiovascular Systems

Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I

Francesco Paneni et al.

EUROPEAN HEART JOURNAL (2013)

Article Biochemical Research Methods

Imaging of neutral lipids by oil red O for analyzing the metabolic status in health and disease

Annika Mehlem et al.

NATURE PROTOCOLS (2013)

Article Cell Biology

Diabetic Nephropathy and Extracellular Matrix

S. O. Kolset et al.

JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2012)

Review Oncology

Kidney injury molecule-1 in renal disease

Femke Waanders et al.

JOURNAL OF PATHOLOGY (2010)

Article Urology & Nephrology

Pathologic Classification of Diabetic Nephropathy

Thijs W. Cohen Tervaert et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)